PCSS-MOUD Exchange 4 – Session Roadmap, Session 3 – Implement/Sustain
Review considerations for MOUD initiation and follow-up, including lab guidelines, and clinical management of patients with continued use (e.g., fentanyl, novel synthetic opioids), overdose risk, poly-substance use, and comorbid mental health conditions. Facilitator: Sherry Larkins, PhD, Director of International Programs and Research Sociologist, Integrated Substance Abuse Programs at the University of California, Los Angeles – Semel […]
PCSS-MOUD Exchange 4 – Session Roadmap, Session 2 – Prepare
Review patient screening considerations and discuss how OUD screening can be integrated into current clinic workflows. Discuss the training and certifications required for specific team members to implement MOUD. Highlight the critical role of Champions, and how to strategically select Champions to support MOUD implementation. Facilitator: Sherry Larkins, PhD, Director of International Programs and Research Sociologist, […]
PCSS-MOUD Exchange 4 – Session Roadmap, Session 1 – Explore
Review medications for opioid use disorders (MOUD), with a focus on buprenorphine treatment and its various formulations. Discuss administrative, clinical and financial considerations, and provide resources for both prescribers and non-prescribers.
PCSS-MOUD Live Half and Half DEA Training
To register, please email Susan Hadley at [email protected]
PCSS-MOUD Exchange 4 – Session Roadmap, Session 1 – Explore
Review medications for opioid use disorders (MOUD), with a focus on buprenorphine treatment and its various formulations. Discuss administrative, clinical and financial considerations, and provide resources for both prescribers and non-prescribers.
PCSS-MOUD Exchange 4 – Session Roadmap, Session 2 – Prepare
Topic: Review patient screening considerations and discuss how OUD screening can be integrated into current clinic workflows. Discuss the training and certifications required for specific team members to implement MOUD. Highlight the critical role of Champions, and how to strategically select Champions to support MOUD implementation.
PCSS-MOUD Exchange 4 – Session Roadmap, Session 3 – Implement/Sustain
Topic: Review considerations for MOUD initiation and follow-up, including lab guidelines, and clinical management of patients with continued use (e.g., fentanyl, novel synthetic opioids), overdose risk, poly-substance use, and comorbid mental health conditions.
PCSS-MOUD Exchange 4 – Session Roadmap, Session 4 – Implement/Sustain
Topic: Consider approaches to sustain MOUD and ensure continued access to high-quality care for our most challenged patients, including those who are pregnant, youth/adolescents, those with acute or chronic pain, and those electing to taper their dose.
PCSS-MOUD Half and Half DEA Training
This training will be split between 2 dates, the first half on 8/4/2025 which will be held virtually and the second half which will be held in person on 8/11/2025 at the address included. To Register for the training please email: [email protected]
PCSS-MOUD Half and Half DEA Training
Training will be hosted virtually To Register, please email [email protected]
